albuvirtide: Clinical Trials

3 trials of albuvirtide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3

Follow albuvirtide: new trials by email Literature Review of albuvirtide trials Research Report on albuvirtide

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection
Albuvirtide, 3BNC117 Antibody - HIV/AIDS
Phase 2UnknownFrontier Biotechnologies Inc.202021-11-302021-09-29
Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 Infection
Albuvirtide, 3BNC117 - HIV/AIDS
Phase 2UnknownFrontier Biotechnologies Inc.242021-05-012021-03-26
Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects
Albuvirtide, 3BNC117, Baseline ART - HIV-1-infection
Phase 2UnknownFrontier Biotechnologies Inc.802018-12-172021-09-29

Conditions studied

Acquired Immunodeficiency Syndrome (2)

Sponsors

Frontier Biotechnologies Inc. (3)

Countries

United States (2)  ·  China (1)

Top investigators

Cheng Yao (1)  ·  Cheng Yao, M.D. (1)

Results publications

PMID 41896772